Back
Corporate News
Alembic Pharmaceuticals to review quarterly, half-year financials at November 4 board meeting
28-Oct-2026, 04:14
Alembic Pharmaceuticals Limited will hold a board meeting on Wednesday, November 4, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, the company said in a filing. The trading window for company securities, which was closed from October 1, 2026, will reopen 48 hours after the financial results are declared.